- Home
- REXR vs SNN Comparison
REXR vs SNN Comparison
Compare REXR & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REXR | SNN |
|---|---|---|
| Founded | 2013 | 1856 |
| Country | United States | United Kingdom |
| Employees | 256 | 16988 |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 14.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | REXR | SNN |
|---|---|---|
| Price | $35.49 | $29.80 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $41.00 | $36.25 |
| AVG Volume (30 Days) | ★ 1.6M | 1.2M |
| Earning Date | 04-23-2026 | 03-16-2026 |
| Dividend Yield | ★ 4.90% | 2.48% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.09 | $8.58 |
| Revenue Next Year | $2.99 | $5.60 |
| P/E Ratio | ★ $43.28 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.14 | $28.40 |
| 52 Week High | $44.38 | $38.79 |
Technical Indicators
Market Signals| Indicator | REXR | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 39.57 |
| Support Level | $34.75 | $29.08 |
| Resistance Level | $36.59 | $33.89 |
| Average True Range (ATR) | 0.66 | 0.50 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 44.16 | 34.06 |
Price Performance
Historical ComparisonAbout REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust focused on owning, operating and acquiring industrial properties in Southern California infill markets. Its goal is to generate attractive risk-adjusted returns for the stockholders by providing superior access to industrial property investments and mortgage debt investments secured by industrial property in high-barrier Southern California infill markets. The company generates revenue from rental income derived from properties in its portfolio.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.